1. Home
  2. ABVC vs XOS Comparison

ABVC vs XOS Comparison

Compare ABVC & XOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVC
  • XOS
  • Stock Information
  • Founded
  • ABVC 2015
  • XOS 2016
  • Country
  • ABVC United States
  • XOS United States
  • Employees
  • ABVC N/A
  • XOS N/A
  • Industry
  • ABVC Biotechnology: Pharmaceutical Preparations
  • XOS Construction/Ag Equipment/Trucks
  • Sector
  • ABVC Health Care
  • XOS Consumer Discretionary
  • Exchange
  • ABVC Nasdaq
  • XOS Nasdaq
  • Market Cap
  • ABVC 22.1M
  • XOS 25.6M
  • IPO Year
  • ABVC N/A
  • XOS N/A
  • Fundamental
  • Price
  • ABVC $3.39
  • XOS $3.46
  • Analyst Decision
  • ABVC
  • XOS Buy
  • Analyst Count
  • ABVC 0
  • XOS 5
  • Target Price
  • ABVC N/A
  • XOS $8.80
  • AVG Volume (30 Days)
  • ABVC 713.8K
  • XOS 22.4K
  • Earning Date
  • ABVC 08-13-2025
  • XOS 08-13-2025
  • Dividend Yield
  • ABVC N/A
  • XOS N/A
  • EPS Growth
  • ABVC N/A
  • XOS N/A
  • EPS
  • ABVC N/A
  • XOS N/A
  • Revenue
  • ABVC $508,383.00
  • XOS $48,678,000.00
  • Revenue This Year
  • ABVC $735.18
  • XOS $1.45
  • Revenue Next Year
  • ABVC N/A
  • XOS $27.16
  • P/E Ratio
  • ABVC N/A
  • XOS N/A
  • Revenue Growth
  • ABVC 1904.43
  • XOS N/A
  • 52 Week Low
  • ABVC $0.40
  • XOS $2.73
  • 52 Week High
  • ABVC $5.48
  • XOS $9.15
  • Technical
  • Relative Strength Index (RSI)
  • ABVC 58.50
  • XOS 62.25
  • Support Level
  • ABVC $3.30
  • XOS $3.30
  • Resistance Level
  • ABVC $3.92
  • XOS $3.59
  • Average True Range (ATR)
  • ABVC 0.65
  • XOS 0.15
  • MACD
  • ABVC -0.04
  • XOS 0.04
  • Stochastic Oscillator
  • ABVC 41.57
  • XOS 79.65

About ABVC ABVC BioPharma Inc.

ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

About XOS Xos Inc.

Xos Inc is a fleet electrification solutions provider committed to the decarbonization of commercial transportation. Xos designs and manufactures Classes 5 through 8 battery-electric commercial vehicles that travel on last-mile, back-to-base routes of up to 200 miles per day. Xos also offers charging infrastructure products and services through Xos Energy Solutions to support electric vehicle fleets. Its products include Stepvan, MDXT, HDXT, Xosphere, and Xos Energy Solutions.

Share on Social Networks: